LeMaitre Vascular, Inc.

NasdaqGM:LMAT Stock Report

Market Cap: US$1.5b

LeMaitre Vascular Past Earnings Performance

Past criteria checks 5/6

LeMaitre Vascular has been growing earnings at an average annual rate of 6.3%, while the Medical Equipment industry saw earnings growing at 11.3% annually. Revenues have been growing at an average rate of 12% per year. LeMaitre Vascular's return on equity is 10.1%, and it has net margins of 15.6%.

Key information

6.3%

Earnings growth rate

3.2%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate12.0%
Return on equity10.1%
Net Margin15.6%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Popularity With Investors Is Clear

May 02
LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Popularity With Investors Is Clear

Is Now The Time To Put LeMaitre Vascular (NASDAQ:LMAT) On Your Watchlist?

Apr 04
Is Now The Time To Put LeMaitre Vascular (NASDAQ:LMAT) On Your Watchlist?

Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Feb 29
Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

What Does LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Share Price Indicate?

Jan 19
What Does LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Share Price Indicate?

Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Paint A Concerning Picture

Oct 27
Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Paint A Concerning Picture

Is It Too Late To Consider Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT)?

Oct 11
Is It Too Late To Consider Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT)?

Does LeMaitre Vascular (NASDAQ:LMAT) Deserve A Spot On Your Watchlist?

Aug 30
Does LeMaitre Vascular (NASDAQ:LMAT) Deserve A Spot On Your Watchlist?

The Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Don't Inspire Confidence

Jul 06
The Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Don't Inspire Confidence

Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$62.3 Based On Its Intrinsic Value?

May 20
Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$62.3 Based On Its Intrinsic Value?

Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?

Mar 12
Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?

Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?

Oct 23
Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?

Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Oct 05
Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

LeMaitre Vascular (NASDAQ:LMAT) Could Be Struggling To Allocate Capital

Sep 13
LeMaitre Vascular (NASDAQ:LMAT) Could Be Struggling To Allocate Capital

LeMaitre Vascular: Reiterate Buy Thesis Following Strong Q2 Numbers

Sep 08

LeMaitre Vascular goes ex dividend tomorrow

Aug 23

LeMaitre Vascular: 16% Return Objective From Idiosyncratic Risk Premia

Jun 24

What Does LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Share Price Indicate?

Jun 15
What Does LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Share Price Indicate?

Are Investors Undervaluing LeMaitre Vascular, Inc. (NASDAQ:LMAT) By 40%?

May 06
Are Investors Undervaluing LeMaitre Vascular, Inc. (NASDAQ:LMAT) By 40%?

LeMaitre Vascular: Steady As She Goes

Apr 07

With EPS Growth And More, LeMaitre Vascular (NASDAQ:LMAT) Is Interesting

Apr 02
With EPS Growth And More, LeMaitre Vascular (NASDAQ:LMAT) Is Interesting

LeMaitre Vascular (NASDAQ:LMAT) Will Want To Turn Around Its Return Trends

Mar 15
LeMaitre Vascular (NASDAQ:LMAT) Will Want To Turn Around Its Return Trends

Revenue & Expenses Breakdown
Beta

How LeMaitre Vascular makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGM:LMAT Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23193307317
30 Sep 23186277016
30 Jun 23177256815
31 Mar 23169216514
31 Dec 22162216213
30 Sep 22160216013
30 Jun 22160225813
31 Mar 22158275512
31 Dec 21154275312
30 Sep 21152285111
30 Jun 21151294910
31 Mar 21135244610
31 Dec 20129214610
30 Sep 20122194710
30 Jun 20115164810
31 Mar 20119185010
31 Dec 1911718499
30 Sep 1911519489
30 Jun 1911118479
31 Mar 1910823469
31 Dec 1810623458
30 Sep 1810321447
30 Jun 1810422447
31 Mar 1810318437
31 Dec 1710117437
30 Sep 179815437
30 Jun 179614436
31 Mar 179312426
31 Dec 168911406
30 Sep 168611396
30 Jun 16829386
31 Mar 16799376
31 Dec 15788375
30 Sep 15767365
30 Jun 15746365
31 Mar 15735364
31 Dec 14704365
30 Sep 14703365
30 Jun 14673365
31 Mar 14652365
31 Dec 13643355
30 Sep 13613345
30 Jun 13593335

Quality Earnings: LMAT has high quality earnings.

Growing Profit Margin: LMAT's current net profit margins (15.6%) are higher than last year (12.8%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: LMAT's earnings have grown by 6.3% per year over the past 5 years.

Accelerating Growth: LMAT's earnings growth over the past year (45.9%) exceeds its 5-year average (6.3% per year).

Earnings vs Industry: LMAT earnings growth over the past year (45.9%) exceeded the Medical Equipment industry 3.3%.


Return on Equity

High ROE: LMAT's Return on Equity (10.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.